Osteoporosis
Conference Coverage
Crystal bone algorithm predicts early fractures, uses ICD codes
This algorithm looks promising and would alert clinicians to often-missed patients with high fracture risk who need to be investigated for...
From the Journals
Vitamin D supplementation shows no COVID-19 prevention
“Vaccination is still the most effective way to protect people from COVID-19, and vitamin D and cod liver oil supplementation should not be...
From the Journals
Strength training overcomes bone effects of vegan diet
Bone microarchitecture differences observed between vegans and omnivores disappear when both practice progressive resistance training.
From the Journals
Alcohol-related cirrhosis associated with higher risk of fractures, death
The higher risk of fractures remained elevated for the first two decades after diagnosis.
Conference Coverage
Vitamin D supplements do not lower risk of fractures
“I would use markers of bone formation as a better measure to determine whether they need vitamin D or not, specifically looking at parathyroid...
Conference Coverage
Osteoporosis risk rises with air pollution levels
Chronic exposure to particulate matter 2.5 mcm or larger in size at concentrations above 25 mcg per cubic meter raised the likelihood of...
Conference Coverage
Abaloparatide works in ‘ignored population’: Men with osteoporosis
Study finds increased bone mineral density from baseline to 1 year in men with osteoporosis.
Conference Coverage
Use of bone densitometry to grade hip OA could be boon to diagnosis, prognosis
A novel, semi-automated scoring system enables dual energy x-ray absorptiometry scans of the hip to be graded and provide useful clinical...
From the Journals
Denosumab boosts bone strength in glucocorticoid users
Compared with risedronate, denosumab promoted bone strength in patients initiating glucocorticoids and those on long-term therapy.
Feature
Doctors treat osteoporosis with hormone therapy against guidelines
Some postmenopausal women may be appropriate candidates for the use of hormone therapy for the prevention of osteoporosis and fractures.
Commentary
Why is vitamin D hype so impervious to evidence?
How many nonsignificant trials do we need before researchers stop studying vitamin D, doctors stop (routinely) measuring levels, and patients stop...